References
- Yang S, Zhang J, Feng C, Huang G. MTHFR 677T variant contributes to diabetic nephropathy risk in Caucasian individuals with type 2 diabetes: A meta-analysis. Metabolism. 2013;62(4):586–594
- Li YY. ENPP1 K121Q polymorphism and type 2 diabetes mellitus in the Chinese population: A meta-analysis including 11 855 subjects. Metabolism. 2012;61(5):625–633
- Ma L, Mondal AK, Murea M, et al. The effect of ACACB cis-variants on gene expression and metabolic traits. PLoS One. 2011;6(8):e23860
- Maeda S, Kobayashi MA, Araki S, et al. A single nucleotide polymorphism within the acetyl-coenzyme A carboxylase beta gene is associated with proteinuria in patients with type 2 diabetes. PLoS Genet. 2010;6:e1000842
- Riancho JA, Vázquez L, García-Pérez MA, et al. Association of ACACB polymorphisms with obesity and diabetes. Mol Genet Metab. 2011;104(4):670–676
- Tang SC, Leung VT, Chan LY, et al. The acetyl-coenzyme A carboxylase beta (ACACB) gene is associated with nephropathy in Chinese patients with type 2 diabetes. Nephrol Dial Transplant. 2010;25:3931–4
- Mooyaart AL, Valk EJ, van Es LA, et al. Genetic associations in diabetic nephropathy: A meta-analysis. Diabetologia. 2011;54:544–553
- Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. Ann Intern Med. 2009;151(4):W65–W94
- Berlin JA, Laird NM, Sacks HS, Chalmers TC. A comparison of statistical methods for combining event rates from clinical trials. Stat Med. 1989;8(2):141–151
- Poole C, Greenland S. Random-effects meta-analyses are not always conservative. Am J Epidemiol. 1999;150:469–475
- Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–748
- DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188
- Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101–129
- Shah VN, Cheema BS, Sharma R, et al. ACACβ gene (rs2268388) and AGTR1 gene (rs5186) polymorphism and the risk of nephropathy in Asian Indian patients with type 2 diabetes. Mol Cell Biochem. 2013;372(1–2):191–198
- Abu-Elheiga L, Matzuk MM, Abo-Hashema KA, Wakil SJ. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science. 2001;291(5513):2613–2616
- Abu-Elheiga L, Oh W, Kordari P, Wakil SJ. Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets. Proc Natl Acad Sci USA. 2003;100(18):10207–10212
- Oh W, Abu-Elheiga L, Kordari P, et al. Glucose and fat metabolism in adipose tissue of acetyl-CoA carboxylase 2 knockout mice. Proc Natl Acad Sci USA. 2005;102(5):1384–1389
- Wakil SJ, Abu-Elheiga LA. Fatty acid metabolism: Target for metabolic syndrome. J Lipid Res. 2009;50:S138–S143
- Wang Z, Jiang T, Li J, et al. Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes. Diabetes. 2005;54(8):2328–2335
- Taneja D, Thompson J, Wilson P, et al. Reversibility of renal injury with cholesterol lowering in hyperlipidemic diabetic mice. J Lipid Res. 2010;51(6):1464–1470
- Wahba IM, Mak RH. Obesity and obesity-initiated metabolic syndrome: Mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol. 2007;2(3):550–562
- Ma L, Murea M, Snipes JA, et al. An ACACB variant implicated in diabetic nephropathy associates with body mass index and gene expression in obese subjects. PLoS One. 2013;8(2):e56193